Five-Year Outcomes: Laparoscopic Greater Curvature Plication for Treatment of Morbid Obesity

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15120%2F17%3A73580964" target="_blank" >RIV/61989592:15120/17:73580964 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216208:11110/17:10364805 RIV/00064165:_____/17:10364805

Výsledek na webu

<a href="http://dx.doi.org/10.1007/s11695-017-2709-3" target="_blank" >http://dx.doi.org/10.1007/s11695-017-2709-3</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1007/s11695-017-2709-3" target="_blank" >10.1007/s11695-017-2709-3</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Five-Year Outcomes: Laparoscopic Greater Curvature Plication for Treatment of Morbid Obesity

Popis výsledku v původním jazyce

Background: Laparoscopic greater curvature plication (LGCP) is a newer metabolic/bariatric surgical procedure that requires no resection, bypass, or implantable device. We report outcomes in a cohort of LGCP patients at 5-year follow-up. Methods: Body mass index (BMI, kg/m2) evolution, excess weight loss (%EWL), excess BMI loss (%EBMIL), and total weight loss (%TWL) were recorded. Repeated-measures analysis of variance (ANOVA) was used to assess BMI change over 5 years. Two-step cluster analysis was used to profile LGCP patients according to significant characteristics relative to successful 5-year weight loss. Results: Of patients entering the study between 2010–2011 with complete weight data through 5-year follow-up (86.9%, 212/244), mean age was 45.8±10.9 years; mean baseline BMI, 41.4±5.5 (81.6% women); 58 patients (27.4%) had type 2 diabetes. Mean operative time was 69.0 minutes; mean hospitalization, 38 hours (24–72). ANOVA indicated a significant BMI reduction out to 2 years (p&lt;0.001), a plateau at 3 and 4 years, and a moderate but significant BMI increase at 5 years (p&lt;0.01). EBMIL at 1, 2, 3, 4, and 5 years was: 50.7±9.1%, 61.5±8.1%, 60.2±7.0%, 58.5±7.0%, and 56.8±6.3%. At 5 years, 79.2% (168/212) of patients were successful; 20.8% (44/212) experienced a suboptimal weight outcome; mean weight regain, 9.2%. Cluster analysis identified 4 distinct LGCP patient profiles. Diabetes improvement rate was 65.5%. There were 12 reoperations (4.9%): 4 emergency (1.6%) and 8 (3.3%) elective. There was no mortality. Conclusions: At 5-year follow-up, LGCP proved to be safe and effective, with 56.8% EBMIL and a low rate of complications.

Název v anglickém jazyce

Five-Year Outcomes: Laparoscopic Greater Curvature Plication for Treatment of Morbid Obesity

Popis výsledku anglicky

Background: Laparoscopic greater curvature plication (LGCP) is a newer metabolic/bariatric surgical procedure that requires no resection, bypass, or implantable device. We report outcomes in a cohort of LGCP patients at 5-year follow-up. Methods: Body mass index (BMI, kg/m2) evolution, excess weight loss (%EWL), excess BMI loss (%EBMIL), and total weight loss (%TWL) were recorded. Repeated-measures analysis of variance (ANOVA) was used to assess BMI change over 5 years. Two-step cluster analysis was used to profile LGCP patients according to significant characteristics relative to successful 5-year weight loss. Results: Of patients entering the study between 2010–2011 with complete weight data through 5-year follow-up (86.9%, 212/244), mean age was 45.8±10.9 years; mean baseline BMI, 41.4±5.5 (81.6% women); 58 patients (27.4%) had type 2 diabetes. Mean operative time was 69.0 minutes; mean hospitalization, 38 hours (24–72). ANOVA indicated a significant BMI reduction out to 2 years (p&lt;0.001), a plateau at 3 and 4 years, and a moderate but significant BMI increase at 5 years (p&lt;0.01). EBMIL at 1, 2, 3, 4, and 5 years was: 50.7±9.1%, 61.5±8.1%, 60.2±7.0%, 58.5±7.0%, and 56.8±6.3%. At 5 years, 79.2% (168/212) of patients were successful; 20.8% (44/212) experienced a suboptimal weight outcome; mean weight regain, 9.2%. Cluster analysis identified 4 distinct LGCP patient profiles. Diabetes improvement rate was 65.5%. There were 12 reoperations (4.9%): 4 emergency (1.6%) and 8 (3.3%) elective. There was no mortality. Conclusions: At 5-year follow-up, LGCP proved to be safe and effective, with 56.8% EBMIL and a low rate of complications.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30212 - Surgery

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2017

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Obesity Surgery

ISSN

0960-8923

e-ISSN

—

Svazek periodika

27

Číslo periodika v rámci svazku

11

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

11

Strana od-do

2818-2828

Kód UT WoS článku

000413428700006

EID výsledku v databázi Scopus

—